Skip to content
Search

Latest Stories

India registers highest single day COVID-19 death toll of 73; total cases cross 31,000

THE death toll due to COVID-19 rose to 1,007 and the number of cases climbed to 31,332 in India on Wednesday (29), according to the health ministry.

The states have recorded over 1,897 cases in last 24 hours, highest number of fresh cases reported in a single day since the pandemic. As many as 73 people succumbed to death on Tuesday (28). Maharashtra has reported 31 deaths followed by Gujarat (19) in a day. As many as 728 new positive COVID-19 cases were reported in Maharashtra.


The number of active COVID-19 cases stood at 22,629, while 7,695 people have recovered, and one patient has migrated, the ministry said. The total number of cases include 111 foreign nationals.

Of the 1,007 deaths, Maharashtra tops the tally with 400 fatalities, followed by Gujarat at 181, Madhya Pradesh at 120, Delhi at 54, Rajasthan at 51, Uttar Pradesh at 34 and Andhra Pradesh at 31.

The death toll reached 26 in Telengana, 25 in Tamil Nadu, 22 in West Bengal while Karantaka has reported 20 deaths. Punjab has registered 19 fatalities so far.

The disease has claimed eight lives in Jammu and Kashmir, four in Kerala while Jharkhand and Haryana have recorded three COVID-19 deaths each. Bihar has reported two deaths, while Meghalaya, Himachal Pradesh, Odisha and Assam have reported one fatality each, according to the ministry's data.

The highest number of confirmed cases in the country are from Maharashtra at 9,318 followed by Gujarat at 3,744, Delhi at 3,314, Madhya Pradesh at 2,387, Rajasthan at 2,364, Tamil Nadu at 2,058 and Uttar Pradesh at 2,053.

The number of COVID-19 cases has gone up to 1,259 in Andhra Pradesh and 1,004 in Telangana. The number of cases has risen to 725 in West Bengal, 565 in Jammu and Kashmir, 523 in Karnataka, 485 in Kerala, 366 in Bihar and 322 in Punjab.

Haryana has reported 310 coronavirus cases, while Odisha has 118 cases. A total of 103 people have been infected with the virus in Jharkhand and 54 in Uttarakhand. Chandigarh has reported 56 cases, Himachal Pradesh has 40 cases while Assam and Chhattisgarh have registered 38 infections each so far. Andaman and Nicobar Islands has 33 COVID-19 cases while Ladakh has reported 22 infections so far.

Meanwhile, India's health ministry has warned that Plasma therapy should only be used for research and trial purposes. The therapy could be life-threatening if it was not administered properly, said Lav Agarwal, joint secretary, health ministry.

India is currently under a nationwide lockdown till May 3 to contain the virus spread.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less